Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
Aguamiel concentrate from Agave salmiana and its extracted saponins attenuated obesity and hepatic steatosis and increased Akkermansia muciniphila in C57BL6 mice.

Scientific reports

Leal-Díaz AM, Noriega LG, Torre-Villalvazo I, Torres N, Alemán-Escondrillas G, López-Romero P, Sánchez-Tapia M, Aguilar-López M, Furuzawa-Carballeda J, Velázquez-Villegas LA, Avila-Nava A, Ordáz G, Gutiérrez-Uribe JA, Serna-Saldivar SO, Tovar AR.
PMID: 27678062
Sci Rep. 2016 Sep 28;6:34242. doi: 10.1038/srep34242.

Obesity and its comorbidities are a severe public health problem worldwide. The use of bioactive compounds found in some foods has been demonstrated to ameliorate the metabolic abnormalities associated with obesity. The purpose of this study was to assess...

Cite
Leal-Díaz AM, Noriega LG, Torre-Villalvazo I, et al. Aguamiel concentrate from Agave salmiana and its extracted saponins attenuated obesity and hepatic steatosis and increased Akkermansia muciniphila in C57BL6 mice. Sci Rep. 2016;6:34242doi: 10.1038/srep34242.
Leal-Díaz, A. M., Noriega, L. G., Torre-Villalvazo, I., Torres, N., Alemán-Escondrillas, G., López-Romero, P., Sánchez-Tapia, M., Aguilar-López, M., Furuzawa-Carballeda, J., Velázquez-Villegas, L. A., Avila-Nava, A., Ordáz, G., Gutiérrez-Uribe, J. A., Serna-Saldivar, S. O., & Tovar, A. R. (2016). Aguamiel concentrate from Agave salmiana and its extracted saponins attenuated obesity and hepatic steatosis and increased Akkermansia muciniphila in C57BL6 mice. Scientific reports, 634242. https://doi.org/10.1038/srep34242
Leal-Díaz, Ana María, et al. "Aguamiel concentrate from Agave salmiana and its extracted saponins attenuated obesity and hepatic steatosis and increased Akkermansia muciniphila in C57BL6 mice." Scientific reports vol. 6 (2016): 34242. doi: https://doi.org/10.1038/srep34242
Leal-Díaz AM, Noriega LG, Torre-Villalvazo I, Torres N, Alemán-Escondrillas G, López-Romero P, Sánchez-Tapia M, Aguilar-López M, Furuzawa-Carballeda J, Velázquez-Villegas LA, Avila-Nava A, Ordáz G, Gutiérrez-Uribe JA, Serna-Saldivar SO, Tovar AR. Aguamiel concentrate from Agave salmiana and its extracted saponins attenuated obesity and hepatic steatosis and increased Akkermansia muciniphila in C57BL6 mice. Sci Rep. 2016 Sep 28;6:34242. doi: 10.1038/srep34242. PMID: 27678062; PMCID: PMC5039706.
Copy Download .nbib Format: NLM
Diet as Regulator of Gut Microbiota and its Role in Health and Disease.

Archives of medical research

Sánchez-Tapia M, Tovar AR, Torres N.
PMID: 31593850
Arch Med Res. 2019 Jul;50(5):259-268. doi: 10.1016/j.arcmed.2019.09.004. Epub 2019 Oct 05.

In recent years, the gut microbiota has been of great interest due to its role in maintaining health and its association with the development of different diseases such as obesity and diabetes. The objective of the present review is...

Cite
Sánchez-Tapia M, Tovar AR, Torres N. Diet as Regulator of Gut Microbiota and its Role in Health and Disease. Arch Med Res. 2019;50(5):259-268doi: 10.1016/j.arcmed.2019.09.004.
Sánchez-Tapia, M., Tovar, A. R., & Torres, N. (2019). Diet as Regulator of Gut Microbiota and its Role in Health and Disease. Archives of medical research, 50(5), 259-268. https://doi.org/10.1016/j.arcmed.2019.09.004
Sánchez-Tapia, Mónica, et al. "Diet as Regulator of Gut Microbiota and its Role in Health and Disease." Archives of medical research vol. 50,5 (2019): 259-268. doi: https://doi.org/10.1016/j.arcmed.2019.09.004
Sánchez-Tapia M, Tovar AR, Torres N. Diet as Regulator of Gut Microbiota and its Role in Health and Disease. Arch Med Res. 2019 Jul;50(5):259-268. doi: 10.1016/j.arcmed.2019.09.004. Epub 2019 Oct 05. PMID: 31593850.
Copy Download .nbib Format: NLM
A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation.

Life sciences

Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, Silva-Palacios A, Cano-Martínez A, González-Reyes S, Jiménez-Osorio AS, Hernández-Pando R, Osorio-Alonso H, Sánchez-Lozada LG, Tovar AR, Pedraza-Chaverri J, Tapia E.
PMID: 34921866
Life Sci. 2021 Dec 16;289:120227. doi: 10.1016/j.lfs.2021.120227. Epub 2021 Dec 16.

BACKGROUND: Ischemic kidney injury is a common clinical condition resulting from transient interruption of the kidney's normal blood flow, leading to oxidative stress, inflammation, and kidney dysfunction. The ketogenic diet (KD), a low-carbohydrate, high-fat diet that stimulates endogenous ketone...

Cite
Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, et al. A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life Sci. 2021;289:120227doi: 10.1016/j.lfs.2021.120227.
Rojas-Morales, P., León-Contreras, J. C., Sánchez-Tapia, M., Silva-Palacios, A., Cano-Martínez, A., González-Reyes, S., Jiménez-Osorio, A. S., Hernández-Pando, R., Osorio-Alonso, H., Sánchez-Lozada, L. G., Tovar, A. R., Pedraza-Chaverri, J., & Tapia, E. (2021). A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life sciences, 289120227. https://doi.org/10.1016/j.lfs.2021.120227
Rojas-Morales, Pedro, et al. "A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation." Life sciences vol. 289 (2021): 120227. doi: https://doi.org/10.1016/j.lfs.2021.120227
Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, Silva-Palacios A, Cano-Martínez A, González-Reyes S, Jiménez-Osorio AS, Hernández-Pando R, Osorio-Alonso H, Sánchez-Lozada LG, Tovar AR, Pedraza-Chaverri J, Tapia E. A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life Sci. 2021 Dec 16;289:120227. doi: 10.1016/j.lfs.2021.120227. Epub 2021 Dec 16. PMID: 34921866.
Copy Download .nbib Format: NLM
Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.

PloS one

Gambato M, Caro-Pérez N, González P, Cañete N, Mariño Z, Lens S, Bonacci M, Bartres C, Sánchez-Tapias JM, Carrión JA, Forns X, Juan M, Pérez-Del-Pulgar S, Londoño MC.
PMID: 28107531
PLoS One. 2017 Jan 20;12(1):e0170913. doi: 10.1371/journal.pone.0170913. eCollection 2017.

[This corrects the article DOI: 10.1371/journal.pone.0166631.].

Cite
Gambato M, Caro-Pérez N, González P, et al. Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon. PLoS One. 2017;12(1):e0170913doi: 10.1371/journal.pone.0170913.
Gambato, M., Caro-Pérez, N., González, P., Cañete, N., Mariño, Z., Lens, S., Bonacci, M., Bartres, C., Sánchez-Tapias, J. M., Carrión, J. A., Forns, X., Juan, M., Pérez-Del-Pulgar, S., & Londoño, M. C. (2017). Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon. PloS one, 12(1), e0170913. https://doi.org/10.1371/journal.pone.0170913
Gambato, Martina, et al. "Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon." PloS one vol. 12,1 (2017): e0170913. doi: https://doi.org/10.1371/journal.pone.0170913
Gambato M, Caro-Pérez N, González P, Cañete N, Mariño Z, Lens S, Bonacci M, Bartres C, Sánchez-Tapias JM, Carrión JA, Forns X, Juan M, Pérez-Del-Pulgar S, Londoño MC. Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon. PLoS One. 2017 Jan 20;12(1):e0170913. doi: 10.1371/journal.pone.0170913. eCollection 2017. PMID: 28107531; PMCID: PMC5249167.
Copy Download .nbib Format: NLM
A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation.

Life sciences

Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, Silva-Palacios A, Cano-Martínez A, González-Reyes S, Jiménez-Osorio AS, Hernández-Pando R, Osorio-Alonso H, Sánchez-Lozada LG, Tovar AR, Pedraza-Chaverri J, Tapia E.
PMID: 34921866
Life Sci. 2021 Dec 16;289:120227. doi: 10.1016/j.lfs.2021.120227. Epub 2021 Dec 16.

BACKGROUND: Ischemic kidney injury is a common clinical condition resulting from transient interruption of the kidney's normal blood flow, leading to oxidative stress, inflammation, and kidney dysfunction. The ketogenic diet (KD), a low-carbohydrate, high-fat diet that stimulates endogenous ketone...

Cite
Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, et al. A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life Sci. 2021;289:120227doi: 10.1016/j.lfs.2021.120227.
Rojas-Morales, P., León-Contreras, J. C., Sánchez-Tapia, M., Silva-Palacios, A., Cano-Martínez, A., González-Reyes, S., Jiménez-Osorio, A. S., Hernández-Pando, R., Osorio-Alonso, H., Sánchez-Lozada, L. G., Tovar, A. R., Pedraza-Chaverri, J., & Tapia, E. (2021). A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life sciences, 289120227. https://doi.org/10.1016/j.lfs.2021.120227
Rojas-Morales, Pedro, et al. "A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation." Life sciences vol. 289 (2021): 120227. doi: https://doi.org/10.1016/j.lfs.2021.120227
Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, Silva-Palacios A, Cano-Martínez A, González-Reyes S, Jiménez-Osorio AS, Hernández-Pando R, Osorio-Alonso H, Sánchez-Lozada LG, Tovar AR, Pedraza-Chaverri J, Tapia E. A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life Sci. 2021 Dec 16;289:120227. doi: 10.1016/j.lfs.2021.120227. Epub 2021 Dec 16. PMID: 34921866.
Copy Download .nbib Format: NLM
Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.

PloS one

Gambato M, Caro-Pérez N, González P, Cañete N, Mariño Z, Lens S, Bonacci M, Bartres C, Sánchez-Tapias JM, Carrión JA, Forns X, Juan M, Pérez-Del-Pulgar S, Londoño MC.
PMID: 27861593
PLoS One. 2016 Nov 18;11(11):e0166631. doi: 10.1371/journal.pone.0166631. eCollection 2016.

Real-life data showed an increased incidence of bacterial infections in patients with advanced liver disease receiving a protease inhibitor (PI)-containing antiviral regimen against hepatitis C (HCV). However, the causes of this event are unknown. We hypothesized that PIs might...

Cite
Gambato M, Caro-Pérez N, González P, et al. Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon. PLoS One. 2016;11(11):e0166631doi: 10.1371/journal.pone.0166631.
Gambato, M., Caro-Pérez, N., González, P., Cañete, N., Mariño, Z., Lens, S., Bonacci, M., Bartres, C., Sánchez-Tapias, J. M., Carrión, J. A., Forns, X., Juan, M., Pérez-Del-Pulgar, S., & Londoño, M. C. (2016). Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon. PloS one, 11(11), e0166631. https://doi.org/10.1371/journal.pone.0166631
Gambato, Martina, et al. "Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon." PloS one vol. 11,11 (2016): e0166631. doi: https://doi.org/10.1371/journal.pone.0166631
Gambato M, Caro-Pérez N, González P, Cañete N, Mariño Z, Lens S, Bonacci M, Bartres C, Sánchez-Tapias JM, Carrión JA, Forns X, Juan M, Pérez-Del-Pulgar S, Londoño MC. Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon. PLoS One. 2016 Nov 18;11(11):e0166631. doi: 10.1371/journal.pone.0166631. eCollection 2016. PMID: 27861593; PMCID: PMC5115763.
Copy Download .nbib Format: NLM
A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation.

Life sciences

Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, Silva-Palacios A, Cano-Martínez A, González-Reyes S, Jiménez-Osorio AS, Hernández-Pando R, Osorio-Alonso H, Sánchez-Lozada LG, Tovar AR, Pedraza-Chaverri J, Tapia E.
PMID: 34921866
Life Sci. 2022 Jan 15;289:120227. doi: 10.1016/j.lfs.2021.120227. Epub 2021 Dec 16.

BACKGROUND: Ischemic kidney injury is a common clinical condition resulting from transient interruption of the kidney's normal blood flow, leading to oxidative stress, inflammation, and kidney dysfunction. The ketogenic diet (KD), a low-carbohydrate, high-fat diet that stimulates endogenous ketone...

Cite
Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, et al. A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life Sci. 2021;289:120227doi: 10.1016/j.lfs.2021.120227.
Rojas-Morales, P., León-Contreras, J. C., Sánchez-Tapia, M., Silva-Palacios, A., Cano-Martínez, A., González-Reyes, S., Jiménez-Osorio, A. S., Hernández-Pando, R., Osorio-Alonso, H., Sánchez-Lozada, L. G., Tovar, A. R., Pedraza-Chaverri, J., & Tapia, E. (2022). A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life sciences, 289120227. https://doi.org/10.1016/j.lfs.2021.120227
Rojas-Morales, Pedro, et al. "A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation." Life sciences vol. 289 (2022): 120227. doi: https://doi.org/10.1016/j.lfs.2021.120227
Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, Silva-Palacios A, Cano-Martínez A, González-Reyes S, Jiménez-Osorio AS, Hernández-Pando R, Osorio-Alonso H, Sánchez-Lozada LG, Tovar AR, Pedraza-Chaverri J, Tapia E. A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life Sci. 2022 Jan 15;289:120227. doi: 10.1016/j.lfs.2021.120227. Epub 2021 Dec 16. PMID: 34921866.
Copy Download .nbib Format: NLM
A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation.

Life sciences

Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, Silva-Palacios A, Cano-Martínez A, González-Reyes S, Jiménez-Osorio AS, Hernández-Pando R, Osorio-Alonso H, Sánchez-Lozada LG, Tovar AR, Pedraza-Chaverri J, Tapia E.
PMID: 34921866
Life Sci. 2021 Dec 16;289:120227. doi: 10.1016/j.lfs.2021.120227. Epub 2021 Dec 16.

BACKGROUND: Ischemic kidney injury is a common clinical condition resulting from transient interruption of the kidney's normal blood flow, leading to oxidative stress, inflammation, and kidney dysfunction. The ketogenic diet (KD), a low-carbohydrate, high-fat diet that stimulates endogenous ketone...

Cite
Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, et al. A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life Sci. 2021;289:120227doi: 10.1016/j.lfs.2021.120227.
Rojas-Morales, P., León-Contreras, J. C., Sánchez-Tapia, M., Silva-Palacios, A., Cano-Martínez, A., González-Reyes, S., Jiménez-Osorio, A. S., Hernández-Pando, R., Osorio-Alonso, H., Sánchez-Lozada, L. G., Tovar, A. R., Pedraza-Chaverri, J., & Tapia, E. (2021). A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life sciences, 289120227. https://doi.org/10.1016/j.lfs.2021.120227
Rojas-Morales, Pedro, et al. "A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation." Life sciences vol. 289 (2021): 120227. doi: https://doi.org/10.1016/j.lfs.2021.120227
Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, Silva-Palacios A, Cano-Martínez A, González-Reyes S, Jiménez-Osorio AS, Hernández-Pando R, Osorio-Alonso H, Sánchez-Lozada LG, Tovar AR, Pedraza-Chaverri J, Tapia E. A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life Sci. 2021 Dec 16;289:120227. doi: 10.1016/j.lfs.2021.120227. Epub 2021 Dec 16. PMID: 34921866.
Copy Download .nbib Format: NLM
A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation.

Life sciences

Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, Silva-Palacios A, Cano-Martínez A, González-Reyes S, Jiménez-Osorio AS, Hernández-Pando R, Osorio-Alonso H, Sánchez-Lozada LG, Tovar AR, Pedraza-Chaverri J, Tapia E.
PMID: 34921866
Life Sci. 2021 Dec 15;120227. doi: 10.1016/j.lfs.2021.120227. Epub 2021 Dec 15.

BACKGROUND: Ischemic kidney injury is a common clinical condition resulting from transient interruption of the kidney's normal blood flow, leading to oxidative stress, inflammation, and kidney dysfunction. The ketogenic diet (KD), a low-carbohydrate, high-fat diet that stimulates endogenous ketone...

Cite
Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, et al. A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life Sci. 2021;120227doi: 10.1016/j.lfs.2021.120227.
Rojas-Morales, P., León-Contreras, J. C., Sánchez-Tapia, M., Silva-Palacios, A., Cano-Martínez, A., González-Reyes, S., Jiménez-Osorio, A. S., Hernández-Pando, R., Osorio-Alonso, H., Sánchez-Lozada, L. G., Tovar, A. R., Pedraza-Chaverri, J., & Tapia, E. (2021). A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life sciences, 120227. https://doi.org/10.1016/j.lfs.2021.120227
Rojas-Morales, Pedro, et al. "A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation." Life sciences vol. (2021): 120227. doi: https://doi.org/10.1016/j.lfs.2021.120227
Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, Silva-Palacios A, Cano-Martínez A, González-Reyes S, Jiménez-Osorio AS, Hernández-Pando R, Osorio-Alonso H, Sánchez-Lozada LG, Tovar AR, Pedraza-Chaverri J, Tapia E. A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life Sci. 2021 Dec 15;120227. doi: 10.1016/j.lfs.2021.120227. Epub 2021 Dec 15. PMID: 34921866.
Copy Download .nbib Format: NLM
The capacity of differentiation of stromal vascular fraction cells into beige adipocytes is markedly reduced in subjects with overweight/obesity and insulin resistance: effect of genistein.

International journal of obesity (2005)

Rodriguez-López LA, Torre-Villalvazo I, Aleman-Escondrillas G, Flores-López A, Guevara-Cruz M, Sánchez-Tapia M, Torre-Anaya EA, Martínez-López V, Vasquez-Reyes S, Torres-Villalobos GM, Macotela Y, Torres N, Tovar AR.
PMID: 34331001
Int J Obes (Lond). 2021 Nov;45(11):2471-2481. doi: 10.1038/s41366-021-00921-3. Epub 2021 Jul 30.

BACKGROUND: Dietary bioactive compounds have been demonstrated to produce several health benefits. Genistein, an isoflavone of soy protein, and resveratrol, a polyphenol from grapes, have been shown to improve insulin sensitivity and to stimulate white adipose tissue (WAT) browning,...

Cite
Rodriguez-López LA, Torre-Villalvazo I, Aleman-Escondrillas G, et al. The capacity of differentiation of stromal vascular fraction cells into beige adipocytes is markedly reduced in subjects with overweight/obesity and insulin resistance: effect of genistein. Int J Obes (Lond). 2021;45(11):2471-2481doi: 10.1038/s41366-021-00921-3.
Rodriguez-López, L. A., Torre-Villalvazo, I., Aleman-Escondrillas, G., Flores-López, A., Guevara-Cruz, M., Sánchez-Tapia, M., Torre-Anaya, E. A., Martínez-López, V., Vasquez-Reyes, S., Torres-Villalobos, G. M., Macotela, Y., Torres, N., & Tovar, A. R. (2021). The capacity of differentiation of stromal vascular fraction cells into beige adipocytes is markedly reduced in subjects with overweight/obesity and insulin resistance: effect of genistein. International journal of obesity (2005), 45(11), 2471-2481. https://doi.org/10.1038/s41366-021-00921-3
Rodriguez-López, Leonardo A, et al. "The capacity of differentiation of stromal vascular fraction cells into beige adipocytes is markedly reduced in subjects with overweight/obesity and insulin resistance: effect of genistein." International journal of obesity (2005) vol. 45,11 (2021): 2471-2481. doi: https://doi.org/10.1038/s41366-021-00921-3
Rodriguez-López LA, Torre-Villalvazo I, Aleman-Escondrillas G, Flores-López A, Guevara-Cruz M, Sánchez-Tapia M, Torre-Anaya EA, Martínez-López V, Vasquez-Reyes S, Torres-Villalobos GM, Macotela Y, Torres N, Tovar AR. The capacity of differentiation of stromal vascular fraction cells into beige adipocytes is markedly reduced in subjects with overweight/obesity and insulin resistance: effect of genistein. Int J Obes (Lond). 2021 Nov;45(11):2471-2481. doi: 10.1038/s41366-021-00921-3. Epub 2021 Jul 30. PMID: 34331001.
Copy Download .nbib Format: NLM
A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation.

Life sciences

Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, Silva-Palacios A, Cano-Martínez A, González-Reyes S, Jiménez-Osorio AS, Hernández-Pando R, Osorio-Alonso H, Sánchez-Lozada LG, Tovar AR, Pedraza-Chaverri J, Tapia E.
PMID: 34921866
Life Sci. 2022 Jan 15;289:120227. doi: 10.1016/j.lfs.2021.120227. Epub 2021 Dec 16.

BACKGROUND: Ischemic kidney injury is a common clinical condition resulting from transient interruption of the kidney's normal blood flow, leading to oxidative stress, inflammation, and kidney dysfunction. The ketogenic diet (KD), a low-carbohydrate, high-fat diet that stimulates endogenous ketone...

Cite
Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, et al. A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life Sci. 2021;289:120227doi: 10.1016/j.lfs.2021.120227.
Rojas-Morales, P., León-Contreras, J. C., Sánchez-Tapia, M., Silva-Palacios, A., Cano-Martínez, A., González-Reyes, S., Jiménez-Osorio, A. S., Hernández-Pando, R., Osorio-Alonso, H., Sánchez-Lozada, L. G., Tovar, A. R., Pedraza-Chaverri, J., & Tapia, E. (2022). A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life sciences, 289120227. https://doi.org/10.1016/j.lfs.2021.120227
Rojas-Morales, Pedro, et al. "A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation." Life sciences vol. 289 (2022): 120227. doi: https://doi.org/10.1016/j.lfs.2021.120227
Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, Silva-Palacios A, Cano-Martínez A, González-Reyes S, Jiménez-Osorio AS, Hernández-Pando R, Osorio-Alonso H, Sánchez-Lozada LG, Tovar AR, Pedraza-Chaverri J, Tapia E. A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation. Life Sci. 2022 Jan 15;289:120227. doi: 10.1016/j.lfs.2021.120227. Epub 2021 Dec 16. PMID: 34921866.
Copy Download .nbib Format: NLM
Bioactive Foods Decrease Liver and Brain Alterations Induced by a High-Fat-Sucrose Diet through Restoration of Gut Microbiota and Antioxidant Enzymes.

Nutrients

Syeda T, Sánchez-Tapia M, Orta I, Granados-Portillo O, Pérez-Jimenez L, Rodríguez-Callejas JD, Toribio S, Silva-Lucero MD, Rivera AL, Tovar AR, Torres N, Perez-Cruz C.
PMID: 35010897
Nutrients. 2021 Dec 22;14(1). doi: 10.3390/nu14010022.

Obesity is associated with cognitive deficit and liver alterations; however, it remains unclear whether a combination of functional foods could reverse cognitive damage and to what extent it would be associated with changes in gut microbiota and liver. With...

Cite
Syeda T, Sánchez-Tapia M, Orta I, et al. Bioactive Foods Decrease Liver and Brain Alterations Induced by a High-Fat-Sucrose Diet through Restoration of Gut Microbiota and Antioxidant Enzymes. Nutrients. 2021;14(1)doi: 10.3390/nu14010022.
Syeda, T., Sánchez-Tapia, M., Orta, I., Granados-Portillo, O., Pérez-Jimenez, L., Rodríguez-Callejas, J. D., Toribio, S., Silva-Lucero, M. D., Rivera, A. L., Tovar, A. R., Torres, N., & Perez-Cruz, C. (2021). Bioactive Foods Decrease Liver and Brain Alterations Induced by a High-Fat-Sucrose Diet through Restoration of Gut Microbiota and Antioxidant Enzymes. Nutrients, 14(1), . https://doi.org/10.3390/nu14010022
Syeda, Tauqeerunnisa, et al. "Bioactive Foods Decrease Liver and Brain Alterations Induced by a High-Fat-Sucrose Diet through Restoration of Gut Microbiota and Antioxidant Enzymes." Nutrients vol. 14,1 (2021). doi: https://doi.org/10.3390/nu14010022
Syeda T, Sánchez-Tapia M, Orta I, Granados-Portillo O, Pérez-Jimenez L, Rodríguez-Callejas JD, Toribio S, Silva-Lucero MD, Rivera AL, Tovar AR, Torres N, Perez-Cruz C. Bioactive Foods Decrease Liver and Brain Alterations Induced by a High-Fat-Sucrose Diet through Restoration of Gut Microbiota and Antioxidant Enzymes. Nutrients. 2021 Dec 22;14(1). doi: 10.3390/nu14010022. PMID: 35010897; PMCID: PMC8746716.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries